Equities

Control Bionics Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
CBL:ASX

Control Bionics Ltd

Actions
Health CareMedical Equipment and Services
  • Price (AUD)0.058
  • Today's Change0.002 / 3.57%
  • Shares traded53.75k
  • 1 Year change+16.00%
  • Beta0.3346
Data delayed at least 20 minutes, as of Feb 10 2026 23:38 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Control Bionics Limited is a medical device company assisting patients whose ability to communicate verbally or via text and social media is compromised by illnesses, such as Motor Neurone Disease and Amyotrophic Lateral Sclerosis. Its products include Control Bionics Trilogy Systems, NeuroStrip, NeuroNode, Cosmos Connect and accessories. NeuroNode technology is a wireless wearable device that detects minute signals sent from the brain to any skeletal muscle and is captured as electromyography output. This output is then sent wirelessly via NeuroNode to a personal computer, enabling speech and other computer-controlled functions like email and texting. Its technology is integrated with eye gaze technology whereby the eye gaze enables a cursor to be moved about a computer screen, driven much like a mouse and the NeuroNode acts like a mouse button. It is commercializing its advancement in its technology, NeuroStrip. It is focused on neuromuscular rehabilitation and athletic optimization.

  • Revenue in AUD (TTM)7.04m
  • Net income in AUD-6.11m
  • Incorporated2005
  • Employees--
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Pathkey.AI Ltd42.15k-1.45m10.93m3.00------259.25-0.0068-0.00680.0002-0.00110.0912--1.31---313.07-178.95---421.77-----3,434.73-351.33---22.292.87---93.01-46.3753.75---41.50--
Adheris Health Ltd62.99m-63.32m13.38m100.00--12.51--0.2123-0.1093-0.10390.10640.00170.9089--6.04---91.35-28.29-174.13-46.3052.2555.43-100.51-29.62---5.000.9431---35.9841.59-2,608.61--27.40--
Adherium Ltd2.01m-12.68m15.45m--------7.70-0.0174-0.01740.0026-0.00530.29960.79591.40---189.21-108.61-1,408.29-166.7432.2149.74-631.44-430.390.1893-89.24-----12.37-2.10-24.01---18.98--
ReNerve Ltd271.71k-3.73m17.19m----3.43--63.25-0.0262-0.02620.00190.0365----------------90.05---1,374.23--6.10-34.480.00--53.19---25.09------
Memphasys Ltd3.70k-5.04m18.81m24.00--3.36--5,083.96-0.0022-0.00220.000.00210.00030.35150.0037---42.63-26.29-85.43-37.53-961.89---136,191.30-16,363.590.1934-6.140.5451---93.83--6.19---23.54--
Resonance Health Ltd11.16m-1.73m20.89m18.00--2.15--1.87-0.0038-0.00380.02450.02040.5848--3.82---9.08-4.17-12.91-4.98-----15.53-9.03---6.570.2882--26.7824.65-1,123.59--19.97--
Control Bionics Ltd7.04m-6.11m23.07m----3.06--3.28-0.0232-0.02320.02610.01830.81584.993.35---70.78-48.07-99.30-55.8071.1468.24-86.77-98.271.08-33.300.0733--16.7616.36-3.30--7.93--
ImExHS Ltd26.35m-4.11m24.32m400.00--1.67--0.9232-0.0861-0.08610.55920.26931.1877.603.3265,869.38-18.42-17.16-27.27-22.8834.4432.57-15.61-21.021.51-10.770.0863--34.4127.4741.00---9.90--
CONNEQT Health Ltd3.55m-18.19m26.94m26.00--38.21--7.58-0.0507-0.05070.010.00120.32350.438910.72---165.59-99.31-618.20-249.1671.9784.29-511.88-208.530.6557-2.370.8527---68.20-5.10-168.93---33.92--
Genetic Signatures Ltd21.36m-20.10m31.80m----0.6348--1.49-0.0899-0.08990.09420.22050.35051.176.04---32.98-16.72-35.71-18.3156.7255.89-94.10-38.679.49-143.040.0156--49.698.55-12.55---17.43--
Atomo Diagnostics Ltd3.79m-4.97m33.22m----4.34--8.76-0.0077-0.00770.00590.00940.36721.072.83---48.13-30.62-57.46-33.1050.6240.54-131.08-113.092.27--0.0259---10.53-6.7227.41---55.73--
Data as of Feb 10 2026. Currency figures normalised to Control Bionics Ltd's reporting currency: Australian Dollar AUD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.